Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (51-60 of 214) with videos related to

Pageof 22
Sort By:
Journal of Neurosurgical Anesthesiology|November 27, 2023
Impact of Intraoperative Fluctuations of Cardiac Output on Cerebrovascular Autoregulation: An Integrative Secondary Analysis of Individual-level DataUrsula Kahl, Linda Krause, Sabrina Amin, et al.
The Prostate|January 9, 2003
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancerAlexander Haese, Markus Graefen, Charlotte Becker, et al.
Urology|December 5, 2006
Development and internal validation of preoperative transition zone prostate cancer nomogramThomas Steuber, Felix K-H Chun, Andreas Erbersdobler, et al.
The Prostate|September 21, 2004
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissueThomas Steuber, Pauliina Niemela, Alexander Haese, et al.
Cancer|October 15, 2008
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lowerJochen Walz, Alexander Haese, Vincenzo Scattoni, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Clinical Chemistry|December 23, 2006
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancerThomas Steuber, Andrew J Vickers, Angel M Serio, et al.
European Urology|June 21, 2002
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancerR Jüri Palisaar, Markus Graefen, Pierre I Karakiewicz, et al.
Cancer|June 17, 2008
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary menFelix K-H Chun, Alexander Haese, Sascha A Ahyai, et al.
Journal of Clinical Monitoring and Computing|June 22, 2020
Comparing the effect of positioning on cerebral autoregulation during radical prostatectomy: a prospective observational studyStefanie Beck, Haissam Ragab, Dennis Hoop, et al.
Pageof 22

Showing results (51-60 of 214) with videos related to

Sort By:
Pageof 22
Journal of Neurosurgical Anesthesiology|November 27, 2023
Impact of Intraoperative Fluctuations of Cardiac Output on Cerebrovascular Autoregulation: An Integrative Secondary Analysis of Individual-level DataUrsula Kahl, Linda Krause, Sabrina Amin, et al.
The Prostate|January 9, 2003
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancerAlexander Haese, Markus Graefen, Charlotte Becker, et al.
Urology|December 5, 2006
Development and internal validation of preoperative transition zone prostate cancer nomogramThomas Steuber, Felix K-H Chun, Andreas Erbersdobler, et al.
The Prostate|September 21, 2004
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissueThomas Steuber, Pauliina Niemela, Alexander Haese, et al.
Cancer|October 15, 2008
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lowerJochen Walz, Alexander Haese, Vincenzo Scattoni, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Clinical Chemistry|December 23, 2006
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancerThomas Steuber, Andrew J Vickers, Angel M Serio, et al.
European Urology|June 21, 2002
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancerR Jüri Palisaar, Markus Graefen, Pierre I Karakiewicz, et al.
Cancer|June 17, 2008
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary menFelix K-H Chun, Alexander Haese, Sascha A Ahyai, et al.
Journal of Clinical Monitoring and Computing|June 22, 2020
Comparing the effect of positioning on cerebral autoregulation during radical prostatectomy: a prospective observational studyStefanie Beck, Haissam Ragab, Dennis Hoop, et al.
Pageof 22